Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East Tech Today.
Press releases published on April 23, 2025

Zentalis Pharmaceuticals Announces Poster Presentation at 2025 ASCO Annual Meeting
SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other …

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BOSTON, April 23, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective on January 31, 2025, the company issued inducement awards …

Cardiff Oncology Announces a Second Patent for the Treatment of mCRC for Bev-Naïve Patients
SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that the United States Patent and …

Candel Therapeutics Announces Oral Presentation of Positive Phase 3 CAN-2409 Results in Localized Prostate Cancer at ASCO 2025
NEEDHAM, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today …

Galapagos Reports First Quarter 2025 Financial Results, Recent Business Highlights and Near-Term Catalysts
First U.S. patient dosed in ATALANTA-1 study of GLPG5101 Mantle cell lymphoma (MCL), a high-unmet-need hematological malignancy, selected as lead indication for the GLPG5101 program; Pivotal development planned to start in 2026 and aiming for approval in …

Galapagos rapporteert resultaten over het eerste kwartaal van 2025, recente hoogtepunten en verwachtingen op korte termijn
Eerste Amerikaanse patiënt gedoseerd in ATALANTA-1 studie met GLPG5101 Mantelcellymfoom (MCL), een hematologische maligniteit met een hoge onvervulde behoefte, geselecteerd als hoofdindicatie voor het GLPG5101-programma; pivotale ontwikkeling gepland voor …

Verses AI Inc. Announces Proposed Public Offering of Securities
VANCOUVER, British Columbia, April 23, 2025 (GLOBE NEWSWIRE) -- Verses AI Inc. (CBOE: VERS)(OTCQB: VRSSD) (“Verses” or the “Company”) is pleased to announce an offering (the “Offering”) of securities in Canada under the base shelf prospectus of the Company …

GWM Unveils its Global Strategy at Auto Shanghai 2025: From China’s GWM to a Global Brand
Baoding, China , April 23, 2025 (GLOBE NEWSWIRE) -- On April 23, 2025, the 21st Shanghai International Automobile Industry Exhibition officially opened. GWM unveiled its exhibition at Hall 7.1, covering over 6,500 square meters, presenting two core product …

United Nations Alliance of Civilizations Meeting in Geneva Concludes with Key Recommendations on AI Governance and Launches HUMAN-AI-T: A Global Initiative to Integrate Humanity into Artificial Intelligence
United Nations Alliance of Civilizations Meeting in Geneva Concludes with Key Recommendations on AI Governance and Launches HUMAN-AI-T: A Global Initiative to Integrate Humanity into Artificial Intelligence UNAOC AI for #OneHumanity: Human-Centered …

La Reunión de la Alianza de Civilizaciones de las Naciones Unidas en Ginebra concluye con recomendaciones clave sobre la gobernanza de la IA y lanza HUMAN-AI-T: una iniciativa global para integrar la humanidad en la inteligencia artificial
La Reunión de la Alianza de Civilizaciones de las Naciones Unidas en Ginebra concluye con recomendaciones clave sobre la gobernanza de la IA y lanza HUMAN-AI-T: una iniciativa global para integrar la humanidad en la inteligencia artificial UNAOC AI for # …

CentralReach Named a Top AI Company of 2025 by the Software Report
Fort Lauderdale, FL, April 23, 2025 (GLOBE NEWSWIRE) -- CentralReach, a leading provider of Autism and IDD Care software for ABA, multidisciplinary, and special education, today announced it has been named to the Software Report’s 2025 Top AI Companies …

Daxtra Brings AI-Powered Recruitment Expertise to Becker’s Healthcare CHRO + Workforce Forum
RICHMOND, Va., April 23, 2025 (GLOBE NEWSWIRE) -- WHO: Daxtra, the leading provider of AI-enriched software for the talent acquisition ecosystem WHAT: Will sponsor the upcoming Becker’s Healthcare Chief Human Resources Officer + Workforce Forum. WHEN: The …

BitMart Announces Leadership Transition: Sheldon Xia to Group President, Nenter Chow Appointed Global CEO
Mahe, Seychelles, April 23, 2025 (GLOBE NEWSWIRE) -- BitMart, a leading global digital asset trading platform, today announced a strategic leadership transition. Founder Sheldon Xia will assume the role of Group President, effective immediately, while …

SynoGut Reviews (ALERT) Consumer Reports Reveal Unexpected Truths Behind Its Ingredients And Side Effects
CANTON, Ohio, April 23, 2025 (GLOBE NEWSWIRE) -- SynoGut is a gut health support supplement that provides a natural way to support a healthy digestive system. The dietary formula is a combination of natural herbs, vitamins, and minerals that are clinically …

Pineal XT Reviews (WARNING) Is It Safe And Worth Trying? Understanding Its Natural Ingredients And Benefits!
ALBANY, N.Y., April 23, 2025 (GLOBE NEWSWIRE) -- Pineal XT is a natural dietary capsule developed and designed to support cognitive functions. It blends in scientifically proven ingredients to enhance brain power, improve mood, stimulate the pineal gland, …

AB Science announces that EMA granted orphan drug status to AB8939 for the treatment of acute myeloid leukemia
PRESS RELEASE EUROPEAN MEDICINES AGENCY (EMA) HAS GRANTED ORPHAN DRUG DESIGNATION IN THE EUROPEAN UNION FOR AB8939 IN THE TREATMENT OF ACUTE MYELOID LEUKEMIA Paris, April 23, 2025, 6.45pm CET AB Science SA (Euronext - FR0010557264 - AB) announces today …

La molécule AB8939 obtient la désignation de médicament orphelin auprès de l'EMA dans le traitement de la leucémie myéloïde aigue
COMMUNIQUE DE PRESSE LA MOLECULE AB8939 OBTIENT LA DESIGNATION DE MEDICAMENT ORPHELIN DANS L’UNION EUROPEENNE AUPRES DE L’AGENCE EUROPEENNE DES MEDICAMENTS (EMA) DANS LE TRAITEMENT DE LA LEUCEMIE MYELOÏDE AIGUE Paris, 23 avril 2025, 18h45 AB Science SA ( …

UPDATE -- HP Announces 2025 Digital Equity Accelerator Cohort
News Highlights: Eight nonprofit organizations in Greece, Indonesia, Nigeria, and Spain selected for the 2025 Digital Equity Accelerator. Organizations are serving disconnected adolescents and adults through digital skills training, education access, and …

Dogecoin and Bitcoin Mining Trending in 2025; Hartcoin Leads the Cloud Mining Revolution Amid Tariff Turmoil.
Cardiff, UK, April 23, 2025 (GLOBE NEWSWIRE) -- As the broader crypto market cools, certain digital assets and innovations continue to stand out. Dogecoin has recently overtaken Tron, climbing back into the top eight cryptocurrencies by market cap, an …

ReversingLabs Named in 2025 Gartner® Market Guide for Software Supply Chain Security
CAMBRIDGE, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- ReversingLabs (RL), the trusted name in file and software security, today announced it has been recognized as a Representative Vendor in the 2025 Gartner® Market Guide for Software Supply Chain Security …